A team led by Prof Kiavash Movahedi (VUB, VIB) has mapped in detail how the immune system acts against pathogens invading the brain. The findings shed new light on host-pathogen interactions and the long-term consequences ...
Oct 12, 2022
0
26
Adding to a growing body of evidence that, for many, problems related to COVID-19 linger longer than the initial infection, researchers at Washington University School of Medicine in St. Louis have found that some people ...
Mar 25, 2022
0
146
In the largest study of its kind, researchers from the Musculoskeletal Research Unit at the University of Bristol have identified the most important risk factors for developing severe infection after knee replacement. Patients ...
Apr 17, 2019
1
62
A study by researchers at the National Institute of Allergy and Infectious Diseases and Duke University helps explain why the candidate vaccine used in the HVTN 505 clinical trial was not protective against HIV infection ...
Jul 30, 2015
0
72
A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research ...
May 25, 2021
0
11
A little more than a year ago, as the first reports rolled in about the outbreak of a novel new coronavirus in China, it quickly became clear that older individuals and males were most at risk of lethal outcomes.
Jan 26, 2021
0
206
Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer ...
Jan 26, 2012
0
1
WEHI researchers have discovered a key differentiation process that provides an essential immune function in helping to control cancer and infectious diseases.
Apr 2, 2021
0
93
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...
A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation's most ...
Mar 9, 2020
0
35
